المؤلفون: Walma, MS, Rombouts, SJ, Brada, LJH, Rinkes, IHB, Bosscha, K, Bruijnen, RC, Busch, OR, Creemers, GJ, Daams, F, van Dam, RM, van Delden, OM, Festen, S, Ghorbani, P, de Groot, DJ, de Groot, JWB, Mohammad, NH, van Hillegersberg, R, de Hingh, IH, D'Hondt, M, Kerver, ED, van Leeuwen, MS, Liem, MS, van Lienden, KP, Los, M, de Meijer, VE, Meijerink, MR, Mekenkamp, LJ, Nio, CY, Abdennabi, IO, Pando, E, Patijn, GA, Polee, MB, Pruijt, JF, Roeyen, G, Ropela, JA, Stommel, MWJ, de Vos-Geelen, J, de Vries, JJ, van der Waal, EM, Wessels, FJ, Wilmink, JW, van Santvoort, HC, Besselink, MG, Molenaar, IQ

المصدر: Trials. 22(1):313

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:146720775

المؤلفون: Hamberg P, Bos MM, Braun HJ, Stouthard JM, van Deijk GA, Erdkamp FL, van der Stelt-Frissen IN, Bontenbal M, Creemers GJ, Portielje JE, Pruijt JF, Loosveld OJ, Smit WM, Muller EW, Schmitz PI, Seynaeve C, Klijn JG, Dutch Breast Cancer Trialists' Group (BOOG)

المصدر: Clinical Breast Cancer; Apr2011, Vol. 11 Issue 2, p103-113, 11p

المؤلفون: Fibbe, WE, Heemskerk, DP, Laterveer, L, Pruijt, JF, Foster, D, Kaushansky, K, Willemze, R

المصدر: Blood; November 1995, Vol. 86 Issue: 9 p3308-3313, 6p

المؤلفون: Walma MS; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Brada LJ; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Patuleia SIS; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Blomjous JG; Dept. of Radiology, OLVG, Amsterdam, the Netherlands., Bollen TL; Dept. of Radiology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Bosscha K; Dept. of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Bruijnen RC; Dept. of Radiology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Busch OR; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Creemers GJ; Dept. of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands., Daams F; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Dam R; Dept. of Surgery, Maastricht UMC+, Maastricht, the Netherlands., Festen S; Dept. of Surgery, OLVG, Amsterdam, the Netherlands., Jan de Groot D; Dept. of Medical Oncology, UMC Groningen, Groningen, the Netherlands., Willem de Groot J; Dept. of Medical Oncology, Isala Clinics, Zwolle, the Netherlands., Mohammad NH; Dept. of Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Hermans JJ; Dept. of Radiology, Radboud University Medical Center, Nijmegen, the Netherlands., de Hingh IH; Dept. of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Kerver ED; Dept. of Medical Oncology, OLVG, Amsterdam, the Netherlands., van Leeuwen MS; Dept. of Radiology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., van der Leij C; Dept. of Radiology, Maastricht UMC+, Maastricht, the Netherlands., Liem MS; Dept. of Surgery, Medical Spectrum Twente, Enschede, the Netherlands., van Lienden KP; Dept. of Radiology Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amstrdam, the Netherlands., Los M; Dept. of Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., de Meijer VE; Dept. of Surgery, UMC Groningen, Groningen, the Netherlands., Meijerink MR; Dept. of Radiology Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amstrdam, the Netherlands., Mekenkamp LJ; Dept. of Medical Oncology, Medical Spectrum Twente, Enschede, the Netherlands., Nederend J; Dept. of Radiology, Catharina Hospital, Eindhoven, the Netherlands., Nio CY; Dept. of Radiology Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amstrdam, the Netherlands., Patijn GA; Dept. of Surgery, Isala Clinics, Zwolle, the Netherlands., Polée MB; Dept. of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Pruijt JF; Dept. of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Renken NS; Dept. of Radiology, Reinier de Graaf Hospital, Delft, the Netherlands., Rombouts SJ; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Schouten TJ; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Stommel MWJ; Dept. of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands., Verweij ME; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., de Vos-Geelen J; Dept. of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, the Netherlands., de Vries JJJ; Dept. of Radiology Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amstrdam, the Netherlands., Vulink A; Dept. of Medical Oncology, Reinier de Graaf Hospital, Delft, the Netherlands., Wessels FJ; Dept. of Radiology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Wilmink JW; Dept. of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam; the Netherlands., van Santvoort HC; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Besselink MG; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: m.g.besselink@amc.nl., Molenaar IQ; Dept. of Surgery, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands.

مؤلفون مشاركون: Dutch Pancreatic Cancer Group

المصدر: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2021 Mar; Vol. 47 (3 Pt B), pp. 699-707. Date of Electronic Publication: 2020 Nov 26.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 8504356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2157 (Electronic) Linking ISSN: 07487983 NLM ISO Abbreviation: Eur J Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatectomy*, Adenocarcinoma/*therapy , Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Pancreatic Neoplasms/*therapy, Adenocarcinoma/pathology ; Aged ; Albumins/administration & dosage ; Antimetabolites, Antineoplastic/therapeutic use ; Cohort Studies ; Deoxycytidine/administration & dosage ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/therapeutic use ; Female ; Fluorouracil/therapeutic use ; Humans ; Irinotecan/therapeutic use ; Leucovorin/therapeutic use ; Male ; Middle Aged ; Neoadjuvant Therapy ; Oxaliplatin/therapeutic use ; Paclitaxel/administration & dosage ; Pancreatic Neoplasms/pathology ; Prospective Studies ; Response Evaluation Criteria in Solid Tumors ; Survival Rate ; Gemcitabine

المؤلفون: Brada LJH; Dept. of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center Amersfoort: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: l.j.brada@amsterdamumc.nl., Walma MS; Dept. of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center Amersfoort: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., van Dam RM; Dept. of Surgery, Maastricht UMC, Maastricht, the Netherlands., de Vos-Geelen J; Dept. of Internal Medicine, Div. of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, the Netherlands., de Hingh IH; Dept. of Surgery, Catharina Hospital, Eindhoven, the Netherlands; Dept. of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands., Creemers GJ; Dept. of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands., Liem MS; Dept. of Surgery, Medical Spectrum Twente, Enschede, the Netherlands., Mekenkamp LJ; Dept. of Medical Oncology, Medical Spectrum Twente, Enschede, the Netherlands., de Meijer VE; Dept. of Surgery, UMC Groningen, Groningen, the Netherlands., de Groot DJA; Dept. of Medical Oncology, UMC Groningen, Groningen, the Netherlands., Patijn GA; Dept. of Surgery, Isala, Zwolle, the Netherlands., de Groot JWB; Isala Oncology Center, Isala, Zwolle, the Netherlands., Festen S; Dept. of Surgery, OLVG, Amsterdam, the Netherlands., Kerver ED; Dept. of Medical Oncology, OLVG, Amsterdam, the Netherlands., Stommel MWJ; Dept. of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands., Meijerink MR; Dept. of Radiology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands., Bosscha K; Dept. of Surgery, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Pruijt JF; Dept. of Medical Oncology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Polée MB; Dept. of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, the Netherlands., Ropela JA; Dept. of Medical Oncology, St Jansdal Hospital, Harderwijk, the Netherlands., Cirkel GA; Dept. of Medical Oncology, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center Amersfoort: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Los M; Dept. of Medical Oncology, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center Amersfoort: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Wilmink JW; Dept. of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Haj Mohammad N; Dept. of Medical Oncology, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center Amersfoort: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., van Santvoort HC; Dept. of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center Amersfoort: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands., Besselink MG; Dept. of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Molenaar IQ; Dept. of Surgery, UMC Utrecht Cancer Center, St Antonius Hospital Nieuwegein and Meander Medical Center Amersfoort: Regional Academic Cancer Center Utrecht, Utrecht, the Netherlands. Electronic address: i.q.molenaar@umcutrecht.nl.

مؤلفون مشاركون: Dutch Pancreatic Cancer Group

المصدر: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] [Pancreatology] 2021 Jan; Vol. 21 (1), pp. 163-169. Date of Electronic Publication: 2020 Dec 03.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Country of Publication: Switzerland NLM ID: 100966936 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1424-3911 (Electronic) Linking ISSN: 14243903 NLM ISO Abbreviation: Pancreatology Subsets: MEDLINE

مواضيع طبية MeSH: Pancreatic Neoplasms/*mortality , Pancreatic Neoplasms/*therapy, Adult ; Age Factors ; Aged ; Aged, 80 and over ; Chemoradiotherapy ; Drug Therapy ; Female ; Humans ; Induction Chemotherapy ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Registries ; Survival Analysis ; Young Adult

المؤلفون: Lugtenburg PJ; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., de Nully Brown P; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., van der Holt B; Haemato Oncology Foundation for Adults in the Netherlands (HOVON) Data Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., D'Amore FA; Aarhus University Hospital, Aarhus, Denmark., Koene HR; St Antonius Hospital, Nieuwegein, the Netherlands., de Jongh E; Albert Schweitzer Hospital, Dordrecht, the Netherlands., Fijnheer R; Meander MC, Amersfoort, the Netherlands., van Esser JW; Amphia Hospital, Breda, the Netherlands., Böhmer LH; Haga Teaching Hospital, The Hague, the Netherlands., Pruijt JF; Jeroen Bosch Hospital, 's Hertogenbosch, the Netherlands., Verhoef GE; University Hospitals Leuven, Leuven, Belgium., Hoogendoorn M; Medical Center Leeuwarden, Leeuwarden, the Netherlands., Bilgin MY; Admiraal de Ruijter Hospital, Goes, the Netherlands., Nijland M; University Medical Center Groningen, Groningen, the Netherlands., van der Burg-de Graauw NC; Bravis Hospital, Roosendaal, the Netherlands., Oosterveld M; Canisius Wilhelmina Hospital, Nijmegen, the Netherlands., Jie KG; Zuyderland Medical Center, Heerlen, the Netherlands., Larsen TS; Odense University Hospital, Odense, Denmark., van der Poel MW; Maastricht University MC, Maastricht, the Netherlands., Leijs MB; Maasstad Hospital, Rotterdam, the Netherlands., Silbermann MH; Tergooi Hospitals, Hilversum, the Netherlands., van Marwijk Kooy M; Isala Hospital, Zwolle, the Netherlands., Beeker A; Spaarne Gasthuis, Hoofddorp, the Netherlands., Kersten MJ; Amsterdam UMC, AMC, Amsterdam, the Netherlands., Doorduijn JK; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Tick LW; Maxima Medical Center, Eindhoven, the Netherlands., Brouwer RE; Reinier de Graaf Hospital, Delft, the Netherlands., Lam KH; Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Burggraaff CN; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., de Keizer B; UMC Utrecht, Utrecht, the Netherlands., Arens AI; Radboud UMC, Nijmegen, the Netherlands., de Jong D; HOVON Pathology Facility and Biobank, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Hoekstra OS; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Zijlstra-Baalbergen JM; Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Oct 10; Vol. 38 (29), pp. 3377-3387. Date of Electronic Publication: 2020 Jul 30.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Lymphoma, Large B-Cell, Diffuse/*drug therapy, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/adverse effects ; Doxorubicin/administration & dosage ; Doxorubicin/adverse effects ; Female ; Follow-Up Studies ; Humans ; Induction Chemotherapy ; Lymphoma, Large B-Cell, Diffuse/diagnostic imaging ; Lymphoma, Large B-Cell, Diffuse/metabolism ; Maintenance Chemotherapy ; Male ; Middle Aged ; Positron Emission Tomography Computed Tomography ; Prednisone/administration & dosage ; Prednisone/adverse effects ; Rituximab/administration & dosage ; Rituximab/adverse effects ; Rituximab/pharmacokinetics ; Treatment Outcome ; Vincristine/administration & dosage ; Vincristine/adverse effects ; Young Adult

المؤلفون: van Erning FN; Department of Research, Netherlands Comprehensive Cancer Organisation, Eindhoven, The Netherlands.; Department of Public Health, Erasmus MC, Rotterdam, The Netherlands., Janssen-Heijnen ML; Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, The Netherlands.; Department of Epidemiology, Maastricht UMC, GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands., Creemers GJ; Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands., Pruijt JF; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Maas HA; Department of Geriatric Medicine, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands., Lemmens VE; Department of Research, Netherlands Comprehensive Cancer Organisation, Eindhoven, The Netherlands.; Department of Public Health, Erasmus MC, Rotterdam, The Netherlands.

المصدر: International journal of cancer [Int J Cancer] 2017 Jan 01; Vol. 140 (1), pp. 224-233. Date of Electronic Publication: 2016 Sep 22.

نوع المنشور: Comparative Study; Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Capecitabine/*administration & dosage , Colorectal Neoplasms/*drug therapy , Colorectal Neoplasms/*pathology , Organoplatinum Compounds/*administration & dosage, Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Capecitabine/therapeutic use ; Colorectal Neoplasms/surgery ; Disease-Free Survival ; Female ; Humans ; Male ; Neoplasm Staging ; Organoplatinum Compounds/therapeutic use ; Oxaliplatin ; Treatment Outcome

المؤلفون: Verhoeff SR; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., van Erning FN; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Eindhoven, The Netherlands.; Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands., Lemmens VE; Department of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Eindhoven, The Netherlands.; Department of Public Health, Erasmus MC University Medical Centre, Rotterdam, The Netherlands., de Wilt JH; Department of Surgery, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands., Pruijt JF; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands.

المصدر: International journal of cancer [Int J Cancer] 2016 Jul 01; Vol. 139 (1), pp. 187-93. Date of Electronic Publication: 2016 Mar 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Chemotherapy, Adjuvant* , Prognosis*, Adenocarcinoma/*drug therapy , Colonic Neoplasms/*drug therapy, Adenocarcinoma/epidemiology ; Adenocarcinoma/pathology ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Clinical Trials as Topic ; Colonic Neoplasms/epidemiology ; Colonic Neoplasms/pathology ; Disease-Free Survival ; Female ; Humans ; Kaplan-Meier Estimate ; Lymph Nodes/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Risk Factors

المؤلفون: van Erning FN; Department of Research, Netherlands Comprehensive Cancer Organisation, Eindhoven, The Netherlands; Department of Public Health, Erasmus MC, Rotterdam, The Netherlands. Electronic address: f.vanerning@iknl.nl., Razenberg LG; Department of Research, Netherlands Comprehensive Cancer Organisation, Eindhoven, The Netherlands; Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands., Lemmens VE; Department of Research, Netherlands Comprehensive Cancer Organisation, Eindhoven, The Netherlands; Department of Public Health, Erasmus MC, Rotterdam, The Netherlands., Creemers GJ; Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands., Pruijt JF; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Maas HA; Department of Geriatric Medicine, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands., Janssen-Heijnen ML; Department of Clinical Epidemiology, VieCuri Medical Centre, Venlo, the Netherlands; Department of Epidemiology, Maastricht UMC, GROW School for Oncology and Developmental Biology, Maastricht, the Netherlands.

المصدر: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2016 Jul; Vol. 61, pp. 1-10. Date of Electronic Publication: 2016 Apr 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Colonic Neoplasms/*drug therapy, Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Capecitabine/administration & dosage ; Chemotherapy, Adjuvant ; Colonic Neoplasms/pathology ; Deoxycytidine/administration & dosage ; Drug Administration Schedule ; Female ; Fluorouracil/administration & dosage ; Humans ; Leucovorin/administration & dosage ; Male ; Multivariate Analysis ; Netherlands ; Organoplatinum Compounds/administration & dosage ; Oxaliplatin

المؤلفون: Ezendam NP; CoRPS - Center of Research on Psychology in Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, The Netherlands; Eindhoven Cancer Registry, Comprehensive Cancer Center the Netherlands, The Netherlands. Electronic address: n.ezendam@iknl.nl., Pijlman B; Department of Obstetrics and Gynecology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. Electronic address: b.pijlman@jbz.nl., Bhugwandass C; Department of Obstetrics and Gynecology, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. Electronic address: Celine.Bhugwandass@radboudumc.nl., Pruijt JF; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands. Electronic address: h.pruijt@jbz.nl., Mols F; CoRPS - Center of Research on Psychology in Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, The Netherlands; Eindhoven Cancer Registry, Comprehensive Cancer Center the Netherlands, The Netherlands. Electronic address: f.mols@uvt.nl., Vos MC; Department of Obstetrics and Gynecology, Elisabeth Tweesteden Hospital, Tilburg and Waalwijk, The Netherlands. Electronic address: c.vos@elisabeth.nl., Pijnenborg JM; Department of Obstetrics and Gynecology, Elisabeth Tweesteden Hospital, Tilburg and Waalwijk, The Netherlands. Electronic address: hpijnenborg@tsz.nl., van de Poll-Franse LV; CoRPS - Center of Research on Psychology in Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, The Netherlands; Eindhoven Cancer Registry, Comprehensive Cancer Center the Netherlands, The Netherlands. Electronic address: l.vdpoll@iknl.nl.

المصدر: Gynecologic oncology [Gynecol Oncol] 2014 Dec; Vol. 135 (3), pp. 510-7. Date of Electronic Publication: 2014 Sep 30.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms/*drug therapy , Ovarian Neoplasms/*pathology , Peripheral Nervous System Diseases/*chemically induced , Peripheral Nervous System Diseases/*pathology, Aged ; Cohort Studies ; Female ; Humans ; Quality of Life ; Surveys and Questionnaires ; Survival Analysis